Purchase Order HHSN268201700059A

<p>This is a firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Genologics Life Sciences Software Inc. for a software license for the Clarity LIMS Gold Edition. The contract has a ceiling value of $119,677.00 and a period of performance ending on September 27, 2016. There is no set-aside designation for this contract. The contract was awarded on September 29, 2015.</p>

This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services, National Institutes of Health, National Heart Lung and Blood Institute to Illumina, Inc., a manufacturer of genomics analysis instruments and reagents. The contract is for a $277,908.00 annual subscription to the Illumina BaseSpace Clarity LIMS software to support the research efforts of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Intramural Research...

This is a firm fixed-price purchase order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a component of the National Institutes of Health (NIH), to Illumina, Inc. for a Laboratory Information Management System (LIMS). The contract has a ceiling value of $371,720.00 and a period of performance ending on December 8, 2027. Illumina, a manufacturer of genomic sequencing and analysis instruments and reagents, has previously received prime and...

This is a firm fixed-price purchase order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency, to Illumina, Inc., a for-profit organization and manufacturer of genetic sequencing and genomic analysis technologies. The $23,443.44 contract has an ultimate completion date of April 30, 2026 and does not utilize any set-aside designations. The contract provides for the procurement of Illumina's advanced sequencing instruments, reagents,...

This is a firm fixed price delivery order awarded to Illumina, Inc. by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency within the National Institutes of Health (NIH). The $92,732.07 contract provides Illumina's sequencing systems, reagents, and bioinformatics products to support genomic sequencing and analysis for research and diagnostic purposes. This delivery order is part of a larger indefinite delivery contract that Illumina holds with the...

This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for maintenance services on an Advanced Biomedical Research Information System (AMBIS) system, with a ceiling value of $13,840 and a completion date of September 22, 2016. The contract does not have a set-aside...

This is a firm fixed price purchase order for $25,000.00 awarded by the National Institute of Environmental Health Sciences, a civilian agency, to Illumina, Inc., a manufacturer of sequencing and genomic analysis equipment, for BASESPACE SOFTWARE LICENSES. The award has no set-aside designation. Illumina has previously received prime federal contracts and subcontracts from agencies like the NIH, CDC, USDA, and VA to provide sequencing systems, reagents, and other products to support genomic...

This is a firm fixed-price purchase order awarded by the National Institute of Environmental Health Sciences (NIEHS), part of the U.S. Department of Health and Human Services, to Illumina, Inc. for annual maintenance of ILLUMINA NEXTBIO licenses. The contract has a ceiling value of $125,000.00 and a period of performance ending on January 31, 2022. Illumina is a for-profit manufacturer of sequencing and analytical instruments and reagents, and has previously been awarded federal contracts and...

This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genomic analysis equipment and software. The contract is for the upgrade and service of Illumina's Genomic Analysis Clarity software. The award is a firm fixed-price purchase order with a ceiling value of $76,040.00 and a period of performance through September 14, 2018. This contract does not have a set-aside designation....

This is a firm fixed-price federal purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to the for-profit manufacturer Illumina, Inc. The contract has a ceiling value of $88,110.00 and an ultimate completion date of April 28, 2020. The contract does not have any set-aside designation. Under this contract, Illumina will provide a range of genomic sequencing systems, reagents, consumables, and related services to the NIH, which conducts biomedical and public...